Largest pharmaceutical companies by total debt
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
AbbVie leads the 35 pharmaceutical companies ranked by total debt, at SEK 686.1B, ahead of Pfizer (SEK 658.6B) and Merck & Co (SEK 501.1B). Figures as of 18 Nov 2026, 20:14 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 35
- First
- AbbVieSEK 686.1B
- Median
- SEK 53.6B
- Combined market value
- SEK 51.48T
- Countries
- 10
- Not ranked
- 26no total debt on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total debt ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | SEK 686.1B | SEK 5.13T | SEK 2,902.84 | 2.47% down | 26% up | ||
| 2 | PfizerPFE · Health Care | SEK 658.6B | SEK 1.63T | SEK 285.58 | 1.32% down | 14% up | ||
| 3 | Merck & CoMRK · Health Care | SEK 501.1B | SEK 3.45T | SEK 1,401.41 | 3.84% down | 51% up | ||
| 4 | Johnson & JohnsonJNJ · Health Care | SEK 487.3B | SEK 6.69T | SEK 2,777.31 | 1.96% down | 38% up | ||
| 5 | Bristol-Myers SquibbBMY · Health Care | SEK 458.5B | SEK 1.24T | SEK 607.85 | 2.53% down | 34% up | ||
| 6 | Eli LillyLLY · Health Care | SEK 432B | SEK 12.54T | SEK 14,081.66 | 2.13% down | 35% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | SEK 310.8B | SEK 691.2B | SEK 216.36 | 1.64% down | 54% up | ||
| 8 | AstraZenecaAZN · Health Care | SEK 301.1B | SEK 2.82T | SEK 1,818.17 | 1.87% down | 2% up | ||
| 9 | NovartisNVS · Health Care | SEK 292B | SEK 2.98T | SEK 1,575.84 | 2.58% down | 25% up | ||
| 10 | SanofiSNY · Health Care | SEK 210.9B | SEK 1.15T | SEK 479.27 | 0.80% down | 4% down | ||
| 11 | Novo NordiskNVO · Health Care | SEK 197.5B | SEK 1.77T | SEK 400.74 | 3.13% down | 17% down | ||
| 12 | GSKGSK · Health Care | SEK 195B | SEK 992.1B | SEK 494.92 | 1.12% down | 6% up | ||
| 13 | ViatrisVTRS · Health Care | SEK 146.5B | SEK 239.8B | SEK 209.19 | 0.64% up | 96% up | ||
| 14 | Abbott LaboratoriesABT · Health Care | SEK 131.4B | SEK 1.85T | SEK 1,065.56 | 0.11% up | 17% down | ||
| 15 | ZoetisZTS · Health Care | SEK 91.9B | SEK 356.3B | SEK 876.91 | 3.34% up | 29% down | ||
| 16 | Royalty PharmaRPRX · Health Care | SEK 91B | SEK 403.9B | SEK 702.48 | 0.63% up | 78% up | ||
| 17 | Jazz PharmaceuticalsJAZZ · Health Care | SEK 54.5B | SEK 160.8B | SEK 2,505.20 | 2.39% up | 37% up | ||
| 18 | GenmabGMAB · Health Care | SEK 53.6B | SEK 320.5B | SEK 519.82 | 1.58% down | 70% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | SEK 40.8B | SEK 136.5B | SEK 273.13 | 3.95% up | 20% up | ||
| 20 | Amneal PharmaceuticalsAMRX · Health Care | SEK 26.1B | SEK 77.1B | SEK 221.24 | 3.05% up | 83% up | ||
| 21 | BridgeBio PharmaBBIO · Health Care | SEK 20.4B | SEK 154.2B | SEK 791.83 | 1.43% up | 17% up | ||
| 22 | Regeneron PharmaceuticalsREGN · Health Care | SEK 20.2B | SEK 997B | SEK 9,637.49 | 1.01% down | 36% up | ||
| 23 | Ionis PharmaceuticalsIONS · Health Care | SEK 18.4B | SEK 47B | SEK 282.27 | 3.00% up | 64% down | ||
| 24 | BeOne MedicinesONC · Health Care | SEK 10.5B | SEK 468.9B | SEK 4,105.23 | 2.27% down | 17% up | ||
| 25 | Ascendis PharmaASND · Health Care | SEK 8.1B | SEK 180.6B | SEK 2,752.86 | 0.13% down | 28% up | ||
| 26 | InsmedINSM · Health Care | SEK 5.6B | SEK 267.6B | SEK 1,219.67 | 1.53% down | 40% down | ||
| 27 | Madrigal PharmaceuticalsMDGL · Health Care | SEK 3.5B | SEK 94.7B | SEK 4,075.80 | 4.98% down | 24% down | ||
| 28 | Legend BiotechLEGN · Health Care | SEK 3.2B | SEK 32B | SEK 164.87 | 0.68% up | 42% down | ||
| 29 | CytokineticsCYTK · Health Care | SEK 2.9B | SEK 72.7B | SEK 521.76 | 0.62% down | 20% down | ||
| 30 | TG TherapeuticsTGTX · Health Care | SEK 2.5B | SEK 101B | SEK 667.98 | 4.79% up | 107% up | ||
| 31 | Cogent BiosciencesCOGT · Health Care | SEK 2.3B | SEK 49.4B | SEK 284.10 | 0.36% up | 20% down | ||
| 32 | Dr. Reddy's LaboratoriesRDY · Health Care | SEK 2B | SEK 127.2B | SEK 152.52 | 1.45% up | 5% up | ||
| 33 | Axsome TherapeuticsAXSM · Health Care | SEK 1.9B | SEK 71.7B | SEK 1,362.63 | 1.39% down | 7% down | ||
| 34 | Rhythm PharmaceuticalsRYTM · Health Care | SEK 1.1B | SEK 83.7B | SEK 1,207.16 | 1.84% up | 13% up | ||
| 35 | Definium TherapeuticsDFTX · Health Care | SEK 412.5M | SEK 40B | SEK 292.34 | 2.11% down | 169% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1647 SEK). 26 companies have no total debt on file and are not ranked here.
Questions and answers
Which pharmaceutical companies rank first by total debt?
AbbVie (SEK 686.1B), Pfizer (SEK 658.6B) and Merck & Co (SEK 501.1B) are the top three of the 35 pharmaceutical companies ranked by total debt as of 18 Nov 2026, 20:14 UTC.
How many pharmaceutical companies are in this ranking?
35 are ranked by total debt. 26 more have no total debt on file and are left out rather than ranked at zero.
What are these pharmaceutical companies worth together?
The 35 pharmaceutical companies ranked by total debt have a combined market value of SEK 51.48T as of 18 Nov 2026, 20:14 UTC.
What does ranking by total debt measure?
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by total debt”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-debt
Underlying data: Yahoo Finance; SEC EDGAR.